Adherence to Competing Strategies for Colorectal Cancer Screening over 3 Years

American Journal of Gastroenterology

Volumn 111, Issue 1, 2016, Pages 105-114

  Liang, Peter S ^a   Wheat, Chelle L ^b   Abhat, Anshu ^b   Brenner, Alison T ^c   Fagerlin, Angela ^d,e   Hayward, Rodney A ^d,e   Thomas, Jennifer P ^f   Vijan, Sandeep ^d,e   Inadomi, John M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d Center for Clinical Management Research   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CHINESE; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HOMOSEXUALITY; HUMAN; INCOME; INTERMETHOD COMPARISON; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MIDDLE AGED; MORTALITY RATE; OCCULT BLOOD TEST; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PATIENT DECISION MAKING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOCIAL STATUS; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; OCCULT BLOOD; PROCEDURES; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; TIME FACTORS;

EID: 84955335069     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2015.367     Document Type: Article

References (43)

1. Levin B, Lieberman DA, McFarland B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570-95.
2. U. S. Preventive Services Task Force. Screening for colorectal cancer: U. S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 149: 627-37.
3. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-71.
4. Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-7.
5. Kronborg O, Fenger C, Olsen J et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-71.
6. Mandel JS, Church TR, Bond JH et al. The eff ect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603-7.
7. Winawer SJ, Zauber AG, Ho MN et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993; 329: 1977-81.
8. Müller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 1995; 155: 1741-8.
9. Inadomi JM, Vijan S, Janz NK et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med 2012; 172: 575-82.
10. Paskett ED, Harrop JP, Wells KJ. Patient navigation: an update on the state of the science. CA Cancer J Clin 2011; 61: 237-49.
11. Peduzzi P, Concato J, Kemper E et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996; 49: 1373-9.
12. Quintero E, Carrillo M, Gimeno-García AZ et al. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening. Gastroenterology 2014; 147: 1021-30.
13. Duncan A, Turnbull D, Wilson C et al. Behavioural and demographic predictors of adherence to three consecutive faecal occult blood test screening opportunities: a population study. BMC Public Health 2014; 14: 238.
14. Rossum LG van, Rijn AF van, Laheij RJ et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008; 135: 82-90.
15. Hoff man RM, Steel S, Yee EFT et al. Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial. Prev Med 2010; 50: 297-9.
16. Liss DT, Petit-Homme A, Feinglass J et al. Adherence to repeat fecal occult blood testing in an urban community health center network. J Community Health 2013; 38: 829-33.
17. Fenton JJ, Elmore JG, Buist DSM et al. Longitudinal adherence with fecal occult blood test screening in community practice. Ann Fam Med 2010; 8: 397-401.
18. Chen LA, Santos S, Jandorf L et al. A program to enhance completion of screening colonoscopy among urban minorities. Clin Gastroenterol Hepatol 2008; 6: 443-50.
19. Redwood D, Provost E, Perdue D et al. The last frontier: innovative eff orts to reduce colorectal cancer disparities among the remote Alaska Native population. Gastrointest Endosc 2012; 75: 474-80.
20. Jandorf L, Braschi C, Ernstoff E et al. Culturally targeted patient navigation for increasing African Americans' adherence to screening colonoscopy: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2013; 22: 1577-87.
21. Percac-Lima S, López L, Ashburner JM et al. The longitudinal impact of patient navigation on equity in colorectal cancer screening in a large primary care network: patient navigation improves CRCS equity. Cancer 2014; 120: 2025-31.
22. Elkin EB, Shapiro E, Snow JG et al. The economic impact of a patient navigator program to increase screening colonoscopy. Cancer 2012; 118: 5982-8.
23. Leddin DJ, Enns R, Hilsden R et al. Canadian Association of Gastroenterology position statement on screening individuals at average risk for developing colorectal cancer: 2010. Can J Gastroenterol 2010; 24: 705-14.
24. Altobelli E, Lattanzi A, Paduano R et al. Colorectal cancer prevention in Europe: burden of disease and status of screening programs. Prev Med 2014; 62: 132-41.
25. Shaukat A, Mongin SJ, Geisser MS et al. Long-term mortality after screening for colorectal cancer. N Engl J Med 2013; 369: 1106-14.
26. Vijan S, Hwang EW, Hofer TP et al. Which colon cancer screening test? A comparison of costs, eff ectiveness, and compliance. Am J Med 2001; 111: 593-601.
27. Zavoral M, Suchanek S, Zavada F et al. Colorectal cancer screening in Europe. World J Gastroenterol 2009; 15: 5907-15.
28. Adler A, Geiger S, Keil A et al. Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany. BMC Gastroenterol 2014; 14: 183.
29. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014; 64: 104-17.
30. Homayoon B, Shahidi NC, Cheung WY. Impact of asian ethnicity on colorectal cancer screening: a population-based analysis. Am J Clin Oncol 2013; 36: 167-73.
31. Lee S, Chen L, Jung MY et al. Acculturation and cancer screening among Asian Americans: role of health insurance and having a regular physician. J Community Health 2014; 39: 201-12.
32. Lasser KE, Murillo J, Lisboa S et al. Colorectal cancer screening among ethnically diverse, low-income patients: a randomized controlled trial. Arch Intern Med 2011; 171: 906-12.
33. Conron KJ, Mimiaga MJ, Landers SJA. Population-based study of sexual orientation identity and gender diff erences in adult health. Am J Public Health 2010; 100: 1953-60.
34. Dilley JA, Simmons KW, Boysun MJ et al. Demonstrating the importance and feasibility of including sexual orientation in public health surveys: health disparities in the Pacifi c Northwest. Am J Public Health 2010; 100: 460-7.
35. Honda K. Factors associated with colorectal cancer screening among the US urban Japanese population. Am J Public Health 2004; 94: 815-22.
36. Jaarsveld CHM van, Miles A, Edwards R et al. Marriage and cancer prevention: does marital status and inviting both spouses together influence colorectal cancer screening participation? J Med Screen 2006; 13: 172-6.
37. James TM, Greiner KA, Ellerbeck EF et al. Disparities in colorectal cancer screening: a guideline-based analysis of adherence. Ethn Dis 2006; 16: 228-33.
38. Walsh JME, Posner SF, Perez-Stable EJ. Colon cancer screening in the ambulatory setting. Prev Med 2002; 35: 209-18.
39. Menees SB, Patel DA, Dalton V. Colorectal cancer screening practices among obstetrician/gynecologists and nurse practitioners. J Womens Health 2009; 18: 1233-8.
40. Martínez-González NA, Tandjung R, Djalali S et al. Eff ects of physiciannurse substitution on clinical parameters: a systematic review and metaanalysis. PloS One 2014; 9: e89181.
41. Martínez-González NA, Djalali S, Tandjung R et al. Substitution of physicians by nurses in primary care: a systematic review and meta-analysis BMC. Health Serv Res 2014; 14: 214.
42. Escoff ery C, Fernandez ME, Vernon SW et al. Patient navigation in a colorectal cancer screening program. J Public Health Manag Pract 2014, 1-8.
43. Bronner K, Mesters I, Weiss-Meilik A et al. Determinants of adherence to screening by colonoscopy in individuals with a family history of colorectal cancer. Patient Educ Couns 2013; 93: 272-81.